2026 Drug Cost Guide: Keytruda, Wegovy, Mounjaro, Zepbound, Opdivo & Imfinzi Prices

Updated U.S. drug cost data (Keytruda, Wegovy, Mounjaro, Zepbound) — Insurance, savings & 2026 trends.

Showing 1 - 6 of 16 drug pricing articles
A Haitian Family’s Journey: Getting Keytruda Treatment in the U.S. - 2026 Drug Cost Analysis

A Haitian Family’s Journey: Getting Keytruda Treatment in the U.S.

30 views

When Marie, a Haitian mother, was diagnosed with metastatic melanoma, her oncologist recommended Keytruda, a groundbreaking immunotherapy. While offering hope, the treatment’s high cost and insurance complexities posed serious challenges. This article explores the latest 2025 pricing, insurance options, and patient assistance programs that make Keytruda accessible for Haitian and U.S. families alike.

Is CAR-T Therapy Covered by Insurance in the U.S.? (2026 Update) - 2026 Drug Cost Analysis

Is CAR-T Therapy Covered by Insurance in the U.S.? (2026 Update)

8 views

CAR-T cell therapy remains one of the most promising yet expensive cancer treatments in 2026. This detailed guide explains whether insurance companies in the U.S. — including Medicare, Medicaid, and private plans — cover CAR-T therapy. We also include updated treatment prices, hospital billing comparisons, and available financial assistance options to help patients manage costs.

How Much Does Keytruda Cost with Insurance in the U.S.? - 2026 Drug Cost Analysis

How Much Does Keytruda Cost with Insurance in the U.S.?

33 views

In 2026, most patients pay between $300 and $3,000 per month depending on their plan, deductible, and location. This complete guide breaks down Keytruda prices with and without insurance, Medicare coverage, patient assistance programs, and expert insights to help Americans save on cancer treatment costs.

Keytruda Cost in 2026: Real Patient Prices, Insurance Coverage & Financial Assistance Explained - 2026 Drug Cost Analysis

Keytruda Cost in 2026: Real Patient Prices, Insurance Coverage & Financial Assistance Explained

32 views

Keytruda (pembrolizumab) remains one of the most prescribed immunotherapy drugs in the U.S. for advanced cancers — but its cost continues to rise. In 2026, real patient prices can vary from $10,500 to $25,000 per infusion cycle before insurance, depending on dosage and treatment setting. This guide breaks down actual out-of-pocket costs, Medicare and private insurance coverage, and patient financial assistance options available in 2026 to help lower expenses.

Keytruda Cost in 2026: What You’ll Actually Pay (Latest U.S. Data & Savings Tips) - 2026 Drug Cost Analysis

Keytruda Cost in 2026: What You’ll Actually Pay (Latest U.S. Data & Savings Tips)

37 views

In 2026, the real cost of Keytruda (pembrolizumab) continues to rise across the U.S., with list prices now reaching $11,564 per 200 mg dose or $23,590 for the 400 mg / 6-week schedule. While insurance coverage, assistance programs, and Medicare options can significantly reduce out-of-pocket costs, many American patients still face bills ranging from $1,200 to $10,000 per month, depending on their plan. This article breaks down updated Keytruda pricing data for 2026, compares infusion costs by hospital and pharmacy, explains copay assistance options, and provides the latest policy updates about potential government price negotiations. You’ll also find detailed FAQs addressing what patients in the U.S. are actually paying, how insurance affects coverage, and where to find verified cost-saving programs. Read on to discover the latest Keytruda prices, insurance breakdowns, and patient support options available in 2026.

How Much Does Keytruda Cost in the US in 2025? - 2026 Drug Cost Analysis

How Much Does Keytruda Cost in the US in 2025?

217 views

How Much Does Keytruda Cost in the US in 2025? Price per Dose, Monthly Cost, and Insurance Coverage Updated: October 1, 2025 Keytruda (pembrolizumab) remains one of the most prescribed immunotherapy treatments for cancers such as melanoma, non-small cell lung cancer, and head and neck cancers. But for patients and families, the most pressing question is often: “How much does Keytruda cost in the US in 2025?” In this guide, we break down the latest Keytruda prices per dose, monthly treatment costs, and annual expenses. We also compare prices from leading sources like GoodRx , Drugs.com , and SingleCare to help you understand the current landscape. Beyond raw prices, we explain how insurance coverage, Medicare, and manufacturer assistance programs can dramatically reduce out-of-pocket costs. If you or a loved one are exploring treatment with Keytruda, this resource provides the most up-to-date 2025 information to help you plan financially and discuss options with your healthcare provider.

Drug Price FAQs: Keytruda, Wegovy, Mounjaro & More

The average cost of Keytruda without insurance in 2026 is around $10,000 to $13,000 per dose. With insurance, out-of-pocket expenses can be as low as $100 depending on the coverage.

Experts expect Zepbound’s price to drop by 10–15% in 2026 as competition and insurance coverage expand. Savings cards and manufacturer programs are also expected to continue.

Wegovy costs between $25 and $150 per month with most insurance plans in the U.S. Without insurance, the price is around $1,350 monthly.

Top Drug Comparisons 2026: Keytruda, Mounjaro, Wegovy & Zepbound

Keytruda vs Opdivo

Compare the 2026 cost, effectiveness, and insurance coverage of both cancer treatments.

Compare Now

Wegovy vs Zepbound

Find out which weight-loss drug offers the best value and results in 2026.

Read Comparison

Mounjaro Savings 2026

Learn how to get the best savings and discounts for Mounjaro through insurance and cards.

See Savings